Wells Fargo & Company Biodesix Inc Transaction History
Wells Fargo & Company
- $468 Billion
- Q2 2025
Shares
18 transactions
Others Institutions Holding BDSX
# of Institutions
45Shares Held
35.9MCall Options Held
0Put Options Held
0-
Telemark Asset Management, LLC Boston, MA8.28MShares$3.4 Million0.75% of portfolio
-
Bryn Mawr Trust CO Bryn Mawr, PA6.1MShares$2.5 Million0.03% of portfolio
-
Birchview Capital, LP Burlington, VT5.74MShares$2.35 Million1.69% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.79MShares$1.56 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.17MShares$891,2900.03% of portfolio
About BIODESIX INC
- Ticker BDSX
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 39,982,000
- Market Cap $16.4M
- Description
- Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...